List of Diagnostics Companies in India - 19

Bilcare is market leader in pharma packaging, packaging innovation and research that partners with the pharmaceutical industry to improve patient health-care outcomes. We endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients. Bilcare PPI offers Innovative Pharmaceutical Packaging Solutions comprising of a wide range of specialty Polymer Films and Aluminum Foils mainly used for packaging of solid dosage pharmaceutical products. Bilcare GCS provides Global Clinical Material Supplies for new drug discovery projects. Bilcare Technologies provides track and trace, authentication and Anti-counterfeit (nCID - nonclonableID) solutions for product & people ID authentication and security. Our other packaging films solutions cater to various industries which includes ID Card industry, Specialty Films Applications and Food packaging. Bilcare's philosophy involves working closely with our customers to develop packaging solutions addressing mainly the core challenges of the pharmaceutical companies --commonly known in Bilcare as "5 Cs" viz. Compliance – directions of dosage administration, Counterfeiting – deterring piracy and counterfeit in medicines packaging; Communication – differentiating and brand recall strategies; Convenience – smart and easy to carry, dispensing; Child Resistant Packaging – to avoid accidental misuse by children). These comprehensive Innovative Packaging Solutions backed with technology helps our Pharma customers to secure and grow their brand in the global market. Bilcare's multiple manufacturing and R&D facilities on Innovative Pharma Packaging Solutions are spread across in Europe, USA and Asia. These facilities together with our global sales force makes us reach and serve our customers to over 100 countries with our wide range products and services.

Cardiotrack is a disruptive healthcare diagnostics solution that is making healthcare delivery more efficient. The mission of Cardiotrack is to reduce the cost of diagnosis by an order of magnitude through innovation in product design, and enhancements in healthcare workflow. Key challenges faced by healthcare providers include – the high cost of diagnostic equipment and lack of trained professionals, especially in semi-urban areas. Cardiotrack is addressing both these issues through the state of the art medical electronics, data analytics, cloud storage and diagnostics workflow management. Cardiotrack focuses on heart health and has consulted with some of the best medical research institutions in India like St John's Research Institute & Jayadeva Institute of Cardiovascular Science in Bangalore; brought onboard doctors and cardiologists as advisers and is collaborating researchers at the Loyola University of Chicago to deliver a comprehensive diagnostics solution for cardiovascular diseases (CVD). Cardiotrack is a multiple parameter handheld diagnostic device including 12-lead ECG monitor, pulse oximeter and blood pressure monitor integrated with mobile-based practice management solution and cloud backend. Low cost, portability and network-connectivity mean that Cardiotrack may be deployed at the primary care level and the resultant scan of the patient can be delivered instantaneously to a specialist anywhere in the world. This approach leads to efficient use of specialists'​ time, enables early diagnosis of heart patients and thus reduces the need for expensive invasive intervention. YouTube: https://www.youtube.com/watch?v=Tj3EI2iC7RE

CrisprBits was started by entrepreneurs and scientists with extensive industry and academic experience, including in the biological sciences. We have prior experience in developing diagnostic solutions, precision medicine and clinical-research solutions that are used by pharmaceutical and biotechnology companies in India and around the world. We are motivated by three guiding principles: using deep science to deliver high quality products; adhering to the highest ethical standards, including in the choice of products we offer; and developing an organization that draws exceptional individuals with diverse backgrounds and affinities. We have offices in Delhi and Bengaluru. Our lab is located in C-CAMP, a premier incubator for biotechnology innovation in Bengaluru.

Curo Biosciences Pvt. Ltd will be creating non-invasive prognosis and diagnosis tools that are painless, affordable and accessible for all.

They are building a molecular oncology facility with a fully equipped laboratory, integrated process platforms, an in-house bioinformatics team, and a huge genetic database for precise and updated reporting

GenePath Diagnostics is a next generation molecular genetics company that provides state-of-the-art clinical in vitro diagnostic services for developing markets and is developing novel next generation diagnostic tests and platforms for the global market. We are an innovation-centric company with a strong emphasis on continuous R&D. We are constantly evolving in pace with global developments in the field and have the ability to develop new tests where needed, e.g. to respond to an emerging pathogen or a rare genetic disorder. We pride ourselves on our ability to work with clinicians to come up with novel or custom solutions to diagnostic problems. At GenePath, we strongly believe in our culture. Our company’s values are the principles and ideals that we live by.

ImmunoScience India Pvt. Ltd. is a pioneering In-vitro Diagnostics (IVD) company dedicated to improving health care with cutting-edge diagnostic technologies. With an emphasis on precision, reliability, and innovation, we aim to provide healthcare professionals with tools that improve patient care and outcomes. ImmunoScience India is an ISO 13485 and ISO 9001 accredited company formed in 2009 with a state-of-the-art manufacturing facility spanning six acres and located approximately 15 kilometers from Pune. The manufacturing facility can manufacture 25000 IVD tests each shift and 2000 uncut sheets for OEM services per shift. The organization manufactures an array of infectious disease tests in rapid, latex and turbilatex and ELISA formats, covering HIV, HBV, HCV, Dengue, Malaria, Typhoid, Leptospira, autoimmune disorders and many others. We prioritize hiring locally to capitalize on the skills and talents available in the communities where our manufacturing facility is located. We invest in training and development programs to empower local workers with the necessary skills and expertise to excel in their roles. By employing local workers, we not only contribute to job creation and economic growth but also foster a sense of ownership and pride in the products they help produce.

Mapmygenome™ uses genomics to personalize health and well-being. Our at-home DNA tests and diagnostic genomic tests provide DNA-based insights that enable consumers, physicians, and health service providers to create a personalized health journey. Established in 2013, Mapmygenome™ has a vision to “Touch 100 million lives and save a million lives by 2030. Some of the preventive genomic tests that Mapmygenome™ offers are Genomepatri, BeautyMap, MyFitGene, Cardiomap, MedicaMap, and MapmyBiome. MapMyGenome also helps people discover their ethnic roots with Genomepatri Heritage.

MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia. We deliver AI-driven and Validated Genetic testing solutions through new-age proprietary tools and technologies to empower the Clinicians for better management of disease cohorts in rare inherited diseases, reproductive genetics, cancer, eye & neurological disorders, diabetes, cardiovascular diseases and more. Our Genetic Reference Lab at Bangalore is the largest CAP accredited lab in South-East Asia, that offers over 1300 genetic tests across different disease areas such as Oncology, Neurology, Cardiology, Ophthalmology and Rare diseases.

Meril's core objective is to design, manufacture and distribute clinically relevant, state-of-the-art and best-in-class medical devices to alleviate human suffering and improve quality of life. We thus have a strong commitment towards R & D and adherence to best quality standards in Manufacturing, Scientific Communication and Distribution known today. Origin Established in 2006, Meril was launched in line with the health-care diversification plan by a large format Indian multi-national company. Disclaimer: Information on Meril Digital / Social Media platform is not intended to be a substitute for professional medical advice, diagnosis or treatment. Meril does not recommend self-management of health issues. For more information, visit: https://www.merillife.com/disclaimer

Morepen Laboratories Limited is an Indian pharmaceutical company founded in 1984. It focuses on providing affordable and high-quality healthcare solutions through innovative pharmaceutical and medical technology products. The company is committed to excellence and aims to make health accessible worldwide. Morepen offers a diverse range of products, including high-quality Active Pharmaceutical Ingredients (APIs) such as Loratadine and Atorvastatin, as well as formulation products across various therapeutic categories like antibiotics and analgesics. The company also has a strong presence in the medical devices sector, particularly with its Blood Glucose and Blood Pressure Monitors. Morepen operates three manufacturing plants in Himachal Pradesh, India, and has a well-equipped R&D center that emphasizes innovation. With a robust distribution network of over 5,100 distributors and 328,000 retail touchpoints in India, Morepen exports its products to more than 50 countries, establishing itself as a significant player in the global generic drug market.

OneCell Diagnostics, Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for applications in clinical cancer care & early-stage clinical trials for Biotech/Pharma companies. ​ OneCell Diagnostics, Inc. is a joint venture between two companies with innovative technologies: Actorius Innovations and Research Pvt Ltd, a leading provider of CTC Tests in India, and Indx.ai, a Silicon Valley based innovative software company specialising in Multi-omics Biomarker Data Analytics.

Prantae is the vision of what lies beyond the boundaries of human imagination. It is a leap-of-faith into 'tomorrow of connected technologies' that empowers each one of the human kind to take control his own health and well-being. It is the canvas of every creative scientist, engineer and doctor who desire to change the face of humanity for better wherever in the galaxy humans ever venture to

Qure.ai is a breakthrough Artificial Intelligence (AI) solution provider that is disrupting the radiology 'status quo' by enhancing imaging accuracy and providing AI assistance for Accelerated Healthcare. The company uses deep learning and AI to make healthcare more accessible and equitable for patients. Qure AI also provides automated interpretation of radiology exams and ultrasound scans, and has raised a total funding of $56M over 5 rounds from healthcare investors.

Welcome to Suraksha Diagnostics! We offer a one-stop integrated solution for pathology and radiology testing, along with medical consultation services. Our comprehensive services are designed to meet the diverse diagnostic needs of our customers, supported by our extensive operational network. Our Strengths: Heritage and Growth: With a strong operating history and a dominant position in our core geography, we continue to expand our business across Kolkata, the remaining east Indian, and adjacent north-east Indian markets. We leverage our extensive network and reputation for quality to capture the growing opportunities in these regions. Technology: Our diagnostic centres are equipped with state-of-the-art radiology and pathology equipment from leading global brands like HORIBA, Schiller Healthcare India, Beckman Coulter, Siemens Healthineers, and more. Our technology is supported by a team of skilled laboratory doctors, radiologists, and technical staff who ensure the highest standards of diagnostic accuracy and reliability. Superior Quality Commitment: We prioritize a customer-centric approach, leading to high satisfaction and retention rates. Our value-added services include home sample collection, house calls, and multiple report delivery options via SMS, email, and web portal, ensuring convenience and accessibility for our customers. Neighbourhood Polyclinics: Many of our diagnostic centres feature associated polyclinics where patients can consult with specialist doctors across various fields, including general physicians, pediatricians, gynecologists, surgeons, cardiologists, neurologists, and more. This integrated approach ensures comprehensive care under one roof. Website https://www.surakshanet.com/ Phone (033) 66191000 Industry Hospitals and Health Care Company size 1,001-5,000 employees Headquarters Kolkata, West Bengal Founded 1992 Specialties Diagnostics, Healthcare, Medical Diagnosis, Pathology, Radiology, and Poly Clinics

Tvaster Genkalp is a Molecular Diagnostics company, established in May 2021, specialising in Liquid Biopsy, offering blood based cancer diagnostic solutions. With innovative approach and commitment to quality, Tvaster has developed a groundbreaking screening test for Hepatocellular carcinoma (HCC) called Episcreen™ Liver. Episcreen™ Liver represents a major leap forward in the early detection of liver cancer (HCC). Rigorously validated through a study involving over 750 patients, this technology has demonstrated exceptional accuracy, far surpassing the current standard blood-based biomarker, AFP. The recent clinical study revealed that Episcreen™ Liver achieved an impressive sensitivity of 90%, in stark contrast to AFP's 50%. Moreover, Episcreen™ Liver identified 92% of HCC cases missed by AFP, offering a potentially life-saving solution for countless individuals. Tvaster is dedicated to enhancing early cancer detection and improving patient outcomes through its state-of-the-art diagnostic solutions.

Vgenomics is an Indian company that aims to diagnose rare diseases with bioinformatics and artificial intelligence (AI). They are committed to addressing rare diseases and improving patient outcomes by analyzing complex genetic information. Vgenomics develops diagnostic and therapeutic solutions for inborn diseases, leveraging genomics and AI to bring novel solutions to the market for over 175 million children suffering from rare diseases.

Provides extraction and diagnostic kits.COVID-19: WobbleBase Bioresearch Pvt Ltd is introducing CovidXtract, a completely ‘Made in India’ Viral RNA extraction kit to facilitate scalling up the testing of COVID-19 in india. This kit is designed to facilitate Mass screening by minimum TAT and without need of any special infrastructure for extraction.